AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H768-H774, 2004. First published October 30, 2003; doi:10.1152/ajpheart.00937.2002
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/2/H768    most recent
00937.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kataoka, C.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kataoka, C.
Right arrow Articles by Takeshita, A.

Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis

Chu Kataoka, Kensuke Egashira, Minako Ishibashi, Shujiro Inoue, Weihua Ni, Ken-ichi Hiasa, Shiro Kitamoto, Makoto Usui, and Akira Takeshita

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyushu University, Fukuoka 812-8582, Japan

Submitted 11 November 2002 ; accepted in final form 8 October 2003

Amlodipine (a new class of calcium channel antagonist) has been shown to limit the progression of arteriosclerosis and decrease the incidence of cardiovascular events. The mechanisms underlying the beneficial effects of amlodipine, however, remain unclear. Therefore, we hypothesized that amlodipine attenuates the development of arteriosclerosis through the inhibition of inflammation in vivo. Long-term inhibition of nitric oxide (NO) by administration of a NO synthase inhibitor, N{omega}-nitro-L-arginine methyl ester (L-NAME), to rats induces coronary vascular inflammation [monocyte infiltration, monocyte chemoattractant protein-1 (MCP-1) expression, increased activity of angiotensin-converting enzyme (ACE)], and arteriosclerosis. Here, we used the rat model to investigate the anti-inflammatory effects of amlodipine in vivo. Treatment with amlodipine markedly inhibited the L-NAME-induced increase in vascular inflammation, oxidative stress, and local ACE and Rho activity and prevented arteriosclerosis. Interestingly, amlodipine prevented the L-NAME-induced increase in MCP-1 receptor CCR2 expression in circulating monocytes. Amlodipine markedly attenuated the high mortality rate at 8 wk of treatment. These data suggest that amlodipine attenuated arteriosclerosis through inhibiting inflammatory disorders in the rat model of long-term inhibition of NO synthesis. The anti-inflammatory effects of amlodipine seem to be mediated not only by the inhibition of local factors such as MCP-1 but also by the decrease in CCR2 in circulating monocytes. Inhibition of the MCP-1 to CCR2 pathway may represent novel anti-inflammatory actions of amlodipine beyond blood pressure lowering.

remodeling; angiotensin; monocytes



Address for reprint requests and other correspondence: K. Egashira, Dept. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu Univ., 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan (E-mail: egashira{at}cardiol.med.kyushu-u.ac.jp).




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. L. Martin-Ventura, J. Tunon, M. C. Duran, L. M. Blanco-Colio, F. Vivanco, and J. Egido
Vascular Protection of Dual Therapy (Atorvastatin-Amlodipine) in Hypertensive Patients
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S189 - S193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Bito, S. Hino, A. Baba, M. Tanaka, H. Watabe, and H. Kawabata
Degradation of oxidative stress-induced denatured albumin in rat liver endothelial cells
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C531 - C542.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. R. Babaev, P. G. Yancey, S. V. Ryzhov, V. Kon, M. D. Breyer, M. A. Magnuson, S. Fazio, and M. F. Linton
Conditional Knockout of Macrophage PPAR{gamma}Increases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1647 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. B. Kahn, K. Boesze-Battaglia, D. W. Stepp, A. Petrov, Y. Huang, R. P. Mason, and T. N. Tulenko
Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H591 - H600.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.